Skip to main content
. 2021 Aug 21;21:940. doi: 10.1186/s12885-021-08663-1

Table 1.

Summary of baseline and follow-up investigations

Required Investigations Baseline 1 month 3 months 6 months 9 months 12 months
Subjective
QLQ-C30 + LC13 X X X X X X
Objective
Physical examination X X X X X X
Toxicity scoring (CTCAE v5) X X X X X X
Management
Medication X X X X X X
Analytic
Blood samples X X X X
Lung function tests PFT, DLCO X X X
Progress CT evaluation X X X X X
SPECT/CT X
Adverse Events X X X X X X